According to U.S. FDA, sigmoidoscope is a class II medical device used in a sigmoidoscopy procedure to examine the rectum and sigmoid colon. Generally, sigmoidoscope is a small tube-like device which consists light source to see the internal part of the rectum and sigmoid colon. Physician or nurse inserts this device into the colon through end part of the large intestine called anus and pushes slowly into the rectum and sigmoid colon. Over the last few decades, prevalence and incidence rates of gastrointestinal diseases (GIT) is increasing notably and is expected to drive the overall GIT diagnosis devices market including sigmoidoscope devices over the forecast period. There are two different types of sigmoidoscopes such as flexible sigmoidoscope and rigid sigmoidoscope are available in the market to cater the patients. Among all, flexible sigmoidoscope devices are commonly used. These devices allow a physician to see around bends in the colon and it provides prominent results in the lower colon examination. Rigid sigmoidoscope is used to check the rectum part and is used less often when compared to flexible sigmoidoscope. In the aforementioned devices, flexible sigmoidoscopes are expected to register robust growth in a CAGR over the forecast period.
Generally, sigmoidscope is used to find the cause of abdominal pain, constipation and diarrhea. Moreover, the device used to find the malignant polyps and benign, as well as early signs of cancer in the lower part of colon and rectum. By using flexible sigmoidoscope device, the physician can see inflammation, intestinal bleeding, ulcers and abnormal growths in the descending colon and rectum. The entire sigmoidoscopy procedure will take 20 minutes to complete and whilst performing the procedure, the patient may feel uncomfortable. Before performing procedure, patient’s rectum and colon must be empty. Moreover, patient has to take only clear liquids for 12 to 24 hours beforehand. Patient has to take edema before performing procedure, so that washes out the intestine.
Increasing prevalence of GIT diseases is one of the major factor which is expected to drive the overall sigmoidoscope devices marker over the forecast period. Moreover, increasing technological advancements in the medical devices industry along with increasing awareness about healthcare is expected to drive the overall market demand for sigmoidoscope devices during forecast period. However, the cost of the procedure and dearth of skilled healthcare professionals in the under developed countries is expected to hamper the marker revenue growth over the forecast period. Moreover, availability of high end medical devices which offer multiple services including sigmoidoscopy is one of the key restraints for this market.
This market can be categorized on three major bases such as product type, application, end user, and geography. On the basis of key products, the market can be classified into flexible sigmoidoscope and rigid sigmoidoscope. Based on the application, the market has been segmented into diagnosis, monitoring. Based on end user type the market has been segmented into hospital, ambulatory surgical centers, and gastroenterology institutes.
Geographically, the sigmoidscope devices market can be classified into five regional markets such as North America (United States and Canada), Europe (Germany, France, United Kingdom, etc.) and Asia-Pacific (Australia, China, Japan, India, etc.), Latin America and rest of the world. The emerging markets in Asia Pacific, Latin America and the Middle East and Africa are expected to register robust growth during the forecast period 2016-2024. This would majorly be attributed to increasing investments by the key players operating in these countries, increasing prevalence of Gastro intestinal track cancers. India, China and Brazil are expected to drive strong growth among the emerging countries, owing to the increasing investments by government bodies to enhance healthcare facilities.
Key companies operating in the global sigmoidscope devices market are Anetic Aid, Parburch Medical Ltd., HIENE USA LTD. Welch Allyn, Jindal Medical & Scientific Instruments Company (Pvt.) Ltd., Pal Surgicals and Evexar Medical, GE Healthcare to name few.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.